Brexit: Issues And Opportunities As UK Life Sciences Define A New Relationship In Europe

Post on 15-Apr-2017

103 views 1 download

Transcript of Brexit: Issues And Opportunities As UK Life Sciences Define A New Relationship In Europe

Brexit: Issues and opportunities as UK life sciences define a new relationship in Europe

Webinar sponsored by

Participants:• Steve Bates, Chief Executive Officer,

BIA

• Virginia Acha, Executive Director, ABPI

• Jo Pisani, Partner, PwC

• Lindsey Barras, Director, PwC

• Harren Jhoti, President and CEO, Astex Pharmaceuticals

• Ian Schofield, Principal Analyst, Scrip

• Sukaina Virji, News Editor, Scrip (Chair)

Steve Bates, Chief Executive Officer, BIA

Virginia Acha, Executive Director, ABPI

Jo Pisani, Partner, PwC

Lindsey BarrasDirectorPwC

Harren JhotiPresident and CEOAstex Pharmaceuticals

Ian SchofieldPrincipal AnalystScrip

Sukaina VirjiNews EditorScrip (Chair)

Brexit: What do we actually know?

What are the key concerns around regulation, people, trade and innovation?

What should be the key elements of the government’s Brexit strategy?

What opportunities does Brexit throw out for UK life sciences?

What happens next on Brexit?

Thank you very much for joining us today. If you have any further questions or comments, please email them to pharma@informa.com

Webinar sponsored by